Community Pharmacy England (CPE) - News updates

Community Pharmacy England met in London on 19th and 20th November, with Committee members considering preparations for the next round of Community Pharmacy Contractual Framework (CPCF) negotiations, ongoing financial pressures, winter readiness and other important matters. Closing the sector’s longstanding funding gap and addressing operational pressures remain the central focus of the Committee. There has [...] The post Upcoming CPCF negotiations the focus at November meeting appeared first on Community Pharmacy England.

The NHSmail programme is being rebranded to NHS.net Connect. This change, announced previously, introduces a refreshed look and new features. Your existing NHS.net email address, login details, and helpdesk support will remain the same. Some NHS.net users will soon see a refreshed homepage and improved features designed to make communication across the NHS easier. The [...] The post NHSmail becoming NHS.net Connect: New Launchpad homepage coming soon appeared first on Community Pharmacy England.

In recent months, Community Pharmacy England has received a number of concerns about EPS pharmacy nominations and re-nominations without patient consent, and wishes to remind pharmacy owners of the relevant Terms of Service requirements and the importance of patient choice of nominated pharmacy. Terms of Service The Terms of Service provide that a pharmacy owner [...] The post Respecting Patient Choice for Pharmacy EPS Nominations appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (28/11/2025) confirmed the following list of price concessions for November 2025: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department. [...] The post November 2025 Price Concessions – 6th Update appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Cefalexin 125mg/5ml oral suspension sugar free and Cefalexin 250mg/5ml oral suspension sugar free is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP077 Cefalexin 125mg/5ml oral suspension sugar free and SSP078 Cefalexin 250mg/5ml oral suspension [...] The post Expiry of SSP077 (Cefalexin 125mg/5ml oral suspension sugar free) & SSP078 (Cefalexin 250mg/5ml oral suspension sugar free) appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 December 2025. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose ampoules Teva UK Ltd 20 unit dose    [...] The post 6 products re-classified as special containers from December 2025 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (27/11/2025) confirmed the following list of price concessions for November 2025: Drug Pack size Price concession Betamethasone 500microgram soluble tablets sugar free 100 £46.65 Cyclizine 50mg/1ml solution for injection ampoules 5 £3.80 Dexamethasone 500microgram tablets 28 £1.87 Fenofibrate micronised 67mg capsules 90 £8.69 Lansoprazole 30mg orodispersible tablets [...] The post November 2025 Price Concessions 5th Update appeared first on Community Pharmacy England.

From 1 December 2025, use of the ‘FS’ prescriber endorsement has been extended to treatments used in the management of tuberculosis (TB) and latent TB infections, including the effects of TB and the adverse effects from TB treatment. Community Pharmacy England has worked closely with DHSC over the past year to secure a workable mechanism [...] The post Use of ‘FS’ endorsement extended to Tuberculosis (TB) treatments appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Baclofen 10mg Tablets (Special Concept Development UK Limited) Drug alert number: EL(25)A/51 Date issued: 27 November 2025 Special Concept Development UK Limited has informed the MHRA that the Patient Information Leaflet (PIL) for the batches listed in this notification do not contain the correct safety information. DMRC reference number: DMRC – [...] The post Class 4 Medicines Defect Notification: Baclofen 10mg Tablets (Special Concept Development UK Limited) appeared first on Community Pharmacy England.

The Chancellor announced her Budget in Parliament today (26th November), setting out the Government’s spending plans for the coming financial year. In terms of healthcare, the Budget commits £300 million of investment in technology to improve patient service and 250 new neighbourhood health centres. The Chancellor went on to say that the Government would be “expanding more [...] The post Chancellor delivers Budget speech appeared first on Community Pharmacy England.